COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Background and Aims: The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level in the United States. We sought to determine the impact of the pandemic on incident HCC cases, clinical characteristics, and tr...

Full description

Bibliographic Details
Main Authors: Bhupinder Kaur, Yee Hui Yeo, Jeff Liang, Michael Luu, Walid Ayoub, Alexander Kuo, Hirsh Trivedi, Kamya Sankar, Jun Gong, Andrew Hendifar, Arsen Osipov, Kambiz Kosari, Nicholas Nissen, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Gastro Hep Advances
Subjects:
Coronavirus Disease 2019 (COVID-19)
Liver Cancer
Underdiagnosis
United States
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572323001863

Internet

http://www.sciencedirect.com/science/article/pii/S2772572323001863

Similar Items